Inhibition of Bcl3 gene expression mediates the anti-proliferative action of estrogen in pituitary lactotrophs in primary culture

Molecular and Cellular Endocrinology

Volumn 345, Issue 1-2, 2011, Pages 68-78

  Mitsui, Tetsuo ^a   Ishida, Maho ^a   Izawa, Michi ^a   Kagami, Yoshihiro ^b   Arita, Jun ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b Ecogenomics Inc   (Japan)

Author keywords

Bcl3; Estrogen; Lactotroph; Proliferation

Indexed keywords

ESTRADIOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 3; RNA; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; BCL3 GENE; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; ENZYME PHOSPHORYLATION; ESTROGEN ACTIVITY; ESTROGEN REGULATED GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; IN VITRO STUDY; NFKAPPAB GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; RAT; REGULATOR GENE; RNA INTERFERENCE; UNINDEXED SEQUENCE;

ANIMALS; CELL PROLIFERATION; ENZYME ACTIVATION; ESTRADIOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LACTOTROPHS; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 80052629040     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.07.021     Document Type: Article

References (60)

1. Arroba A.I., Frago L.M., Argente J., Chowen J.A. Oestrogen requires the insulin-like growth factor-1 receptor for stimulation of prolactin synthesis via mitogen-activated protein kinase. J. Neuroendocrinol. 2005, 17:97-104.
2. Bours V., Franzoso G., Azarenko V., Park S., Kanno T., Brown K., Siebenlist U. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell 1993, 72:729-739.
3. Bower K.E., Zeller R.W., Wachsman W., Martinez T., McGuire K.L. Correlation of transcriptional repression by p21(SNFT) with changes in DNA.NF-AT complex interactions. J. Biol. Chem. 2002, 277:34967-34977.
4. Dechend R., Hirano F., Lehmann K., Heissmeyer V., Ansieau S., Wulczyn F.G., Scheidereit C., Leutz A. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators. Oncogene 1999, 18:3316-3323.
5. Deffenbacher, K.E., Shull, J.D., 2006. Effects of diethylstilbestrol (DES) on the anterior pituitary gland of the ACI, Copenhagen and Brown Norway rat. GEO accession GSE4028, Gene Expression Omnibus, NCBI.
6. Deng J., Miller S.A., Wang H.Y., Xia W., Wen Y., Zhou B.P., Li Y., Lin S.Y., Hung M.C. β-catenin interacts with and inhibits NF-κB in human colon and breast cancers. Cancer Cell 2002, 2:323-334.
7. Dickson R.B., Lippman M.E. Growth factors in breast cancer. Endocr. Rev. 1995, 16:559-589.
8. Dubey R.K., Gillespie D.G., Jackson E.K., Keller P.J. 17β-Estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension 1998, 31:522-528.
9. Fenwick C., Na S.Y., Voll R.E., Zhong H., Im S.Y., Lee J.W., Ghosh S. A subclass of Ras proteins that regulate the degradation of IκB. Science 2000, 287:869-873.
10. Fiorelli G., Picariello L., Martineti V., Tonelli F., Brandi M.L. Functional estrogen receptor β in colon cancer cells. Biochem. Biophys. Res. Commun. 1999, 261:521-527.
11. Foster J.S., Henley D.C., Ahamed S., Wimalasena J. Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol. Metab. 2001, 12:320-327.
12. Fujimoto N., Igarashi K., Kanno J., Honda H., Inoue T. Identification of estrogen-responsive genes in the GH3 cell line by cDNA microarray analysis. J. Steroid Biochem. Mol. Biol. 2004, 91:121-129.
13. Fujita T., Nolan G.P., Liou H.C., Scott M.L., Baltimore D. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev. 1993, 7:1354-1363.
14. Fukamachi H., McLachlan J.A. Proliferation and differentiation of mouse uterine epithelial cells in primary serum-free culture: estradiol-17β suppresses uterine epithelial proliferation cultured on a basement membrane-like substratum. In Vitro Cell Dev. Biol. 1991, 27A:907-913.
15. Ghisletti S., Meda C., Maggi A., Vegeto E. 17β-estradiol inhibits inflammatory gene expression by controlling NF-κB intracellular localization. Mol. Cell. Biol. 2005, 25:2957-2968.
16. Ghosh S., May M., Kopp E. NF-κB and Rel proteins: evolutionally conserved mediators of immune responses. Ann. Rev. Immmunol. 1998, 16:225-260.
17. Gould K.A., Shull J.D., Gorski J. DES action in the thymus: inhibition of cell proliferation and genetic variation. Mol. Cell. Endocrinol. 2000, 170:31-39.
18. Harnish D.C., Scicchitano M.S., Adelman S.J., Lyttle C.R., Karathanasis S.K. The role of CBP in estrogen receptor cross-talk with nuclear factor-κB in HepG2 cells. Endocrinology 2000, 141:3403-3411.
19. Heaney A.P., Horwitz G.A., Wang Z., Singson R., Melmed S. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat. Med. 1999, 5:1317-1321.
20. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Ström A., Treuter E., Warner M., Gustafsson J.A. Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 2007, 87:905-931.
21. Henderson I.C., Canellos G.P. Cancer of the breast: the past decade. New Eng. J. Med. 1980, 302:17-30.
22. Holli K., Isola J., Cuzick J. Low biologic aggressiveness in breast cancer in women using hormone replacement therapy. J. Clin. Oncol. 1998, 16:3115-3120.
23. Iacobelli M., Wachsman W., McGuire K.L. Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein. J. Immunol. 2000, 165:860-868.
24. Ishida M., Mitsui T., Yamakawa K., Sugiyama N., Takahashi W., Shimura H., Endo T., Kobayashi T., Arita J. Involvement of cAMP response element-binding protein in the regulation of cell proliferation and the prolactin promoter of lactotrophs in primary culture. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E1529-E1537.
25. Jiang S.Y., Jordan V.C. Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor. J. Natl. Cancer Inst. 1992, 84:580-591.
26. Kalaitzidis D., Gilmore T.D. Transcription factor cross-talk: the estrogen receptor and NF-κB. Trends Endocrinol. Metab. 2005, 16:46-52.
27. Kang S.M., Tran A.C., Grilli M., Lenardo M.J. NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science 1992, 256:1452-1456.
28. Kawashima K., Yamakawa K., Arita J. Involvement of phosphoinositide-3-kinase and p70 S6 kinase in regulation of proliferation of rat lactotrophs in culture. Endocrine 2000, 13:385-392.
29. Kawashima K., Yamakawa K., Takahashi W., Takizawa S., Yin P., Sugiyama N., Kanba S., Arita J. The estrogen-occupied estrogen receptor functions as a negative regulator to inhibit cell proliferation induced by insulin/IGF-1: a cell context-specific antimitogenic action of estradiol on rat lactotrophs in culture. Endocrinology 2002, 143:2750-2758.
30. Kushner P.J., Hort E., Shine J., Baxter J.D., Greene G.L. Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol. Endocrinol. 1990, 4:1465-1473.
31. Levin E.R. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol. Endocrinol. 2003, 17:309-317.
32. Liu H., Lee E.S., Gajdos C., Pearce S.T., Chen B., Osipo C., Loweth J., McKian K., De Los Reyes A., Wing L., Jordan V.C. Apoptotic action of 17β-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo. J. Natl. Cancer Inst. 2003, 95:1586-1597.
33. Maminnta M.L., Molteni A., Rosen S.T. Stable expression of the human estrogen receptor in HeLa cells by infection: effect of estrogen on cell proliferation and c-myc expression. Mol. Cell. Endocrinol. 1994, 78:61-69.
34. Manna S.K., Aggarwal B.B. Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression. J. Immunol. 1999, 162:2095-2102.
35. Mitsui T., Taniguchi N., Kawasaki N., Kagami Y., Arita J. Fetal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin induces expression of the chemokine genes Cxcl4 and Cxcl7 in the perinatal mouse brain. J. Appl. Toxicol. 2011, 31:279-284.
36. Morey A.K., Pedram A., Razandi M., Prins B.A., Hu R.M., Biesiada E., Levin E.R. Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology 1997, 138:3330-3339.
37. Na S.Y., Choi J.E., Kim H.J., Jhun B.H., Lee Y.C., Lee J.W. Bcl3, an IκB protein, stimulates activating protein-1 transactivation and cellular proliferation. J. Biol. Chem. 1999, 274:28491-28496.
38. Paez-Pereda M., Giacomini D., Refojo D., Nagashima A.C., Hopfner U., Grubler Y., Chervin A., Goldberg V., Goya R., Hentges S.T., Low M.J., Holsboer F., Stalla G.K., Arzt E. Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc. Natl. Acad. Sci. USA 2003, 100:1034-1039.
39. Park S.G., Chung C., Kang H., Kim J.Y., Jung G. Up-regulation of cyclin D1 by HBx is mediated by NF-κB2/BCL3 complex through κB site of cyclin D1 promoter. J. Biol. Chem. 2006, 281:31770-31777.
40. Pierce J.W., Schoenleber R., Jesmok G., Best J., Moore S.A., Collins T., Gerritsen M.E. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J. Biol. Chem. 1997, 272:21096-21103.
41. Plaksin D., Baeuerle P.A., Eisenbach L. KBF1 (p50 NF-κB homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells. J. Exp. Med. 1993, 177:1651-1662.
42. Pratt M.A.C., Bishop T.E., White D., Yasvinski G., Ménard M., Niu M.Y., Clarke R. Estrogen withdrawal-induced NF-κB activity and Bcl-3 expression in breast cancer cells: roles in growth and hormone independence. Mol. Cell. Biol. 2003, 23:6887-6900.
43. Rajkumar L., Guzman R., Yang J., Thordarson G., Talamantes F., Nandi S. Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc. Natl. Acad. Sci. USA 2001, 98:11755-11759.
44. Rocha S., Martin A.M., Meek D.W., Perkins N.D. p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-κB subunit with histone deacetylase 1. Mol. Cell. Biol. 2003, 23:4713-4727.
45. Simoncini T., Maffei S., Basta G., Barsacchi G., Genazzani A.R., Liao J.K., De Caterina R. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ. Res. 2000, 87:19-25.
46. Song J.Y., Jin L., Lloyd R.V. Effects of estradiol on prolactin and growth hormone messenger RNAs in cultured normal and neoplastic (MtT/W15 and GH3) rat pituitary cells. Cancer Res. 1989, 49:1247-1253.
47. Sonnenschein C., Szelei J., Nye T.L., Soto A.M. Control of cell proliferation of human breast MCF7 cells; serum and estrogen resistant variants. Oncol. Res. 1994, 6:373-381.
48. Stein B., Yang M.X. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-κB and C/EBPβ. Mol. Cell. Biol. 1995, 15:4971-4979.
49. Stender J.D., Frasor J., Komm B., Chang K.C.N., Kraus W.L., Katzenellenbogen B.S. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation. Mol. Endocrinol. 2007, 21:2112-2123.
50. Suzuki S., Yamamoto I., Arita J. Mitogen-activated protein kinase-dependent stimulation of proliferation of rat lactotrophs in culture by 3',5'-cyclic adenosine monophosphate. Endocrinology 1999, 140:2850-2858.
51. Wang X., Belguise K., Kersual N., Kirsch K.H., Mineva N.D., Galtier F., Chalbos D., Sonenshein G.E. Oestrogen signaling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat. Cell Biol. 2007, 9:470-478.
52. Wang Z., Mitsui T., Ishida M., Arita J. Adenovirus vectors differentially modulate proliferation of pituitary lactotrophs in primary culture in a mitogen and infection time-dependent manner. J. Endocrinol. 2008, 198:209-217.
53. Wang L.H., Yang X.Y., Mihalic K., Xiao W., Li D., Farrar W.L. Activation of estrogen receptor blocks interleukin-6-induced cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STS3 mediated by co-regulator PIAS3. J. Biol. Chem. 2001, 276:31839-31844.
54. Weisz A., Bresciani F. Estrogen regulation of proto-oncogenes coding for nuclear proteins. Crit. Rev. Oncog. 1993, 4:361-388.
55. Wendell D.L., Platts A., Land S. Global analysis of gene expression in the estrogen induced pituitary tumor of the F344 rat. J. Steroid Biochem. Mol. Biol. 2006, 101:188-196.
56. Westerheide S.D., Mayo M.W., Anest V., Hanson J., Baldwin A.S.J. The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G1 transition. Mol. Cell. Biol. 2001, 21:8428-8436.
57. Wynick D., Hammond P.J., Akinsanya K.O., Bloom S.R. Galanin regulates basal and oestrogen-stimulated lactotroph function. Nature 1993, 364:529-532.
58. Zajchowski D.A., Sager R., Webster L. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res. 1993, 53:5004-5011.
59. Zhang L., Cui R., Cheng X., Du J. Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism activating IκB kinase. Cancer Res. 2005, 65:457-464.
60. Zhu P., Baek S.H., Bourk E.M., Ohgi K.A., Garcia-Bassets I., Sanjo H., Akira S., Kotol P.F., Glass C.K., Rosenfeld M.G., Rose D.W. Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 2006, 124:615-629.